FDA: PharMEDium recalls 55 lots of compounded sterile drugs

Editor's Note

The Food and Drug Administration on January 2 announced the recall by PharMEDium Services (Lake Forest, Illinois) of 55 lots (impacting 25,327 units) of compounded sterile drug products because of a lack of sterility assurance.

The recalled products were manufactured in PharMEDium’s Memphis location and distributed nationwide to hospitals and clinics.

Posted 01/02/2018] AUDIENCE: Risk Manager, Pharmacy ISSUE: PharMEDium Services is voluntarily recalling certain lots of drug products to the hospital/user level due to a lack of assurance of sterility. Administration of a drug product intended to be sterile that is not sterile could result in serious infections that may be life-threatening.

Read More >>